HMGB1 and obesity due to melanocortin 4 receptor deficiency: Interventions targeting the HMGB1 pathway may potentiate adipose tissue metabolic activity and improve metabolic health, offering a promising therapeutic avenue for millions affected by obesity-related conditions.